-
公开(公告)号:US20120130147A1
公开(公告)日:2012-05-24
申请号:US13358191
申请日:2012-01-25
申请人: Dirk FINSINGER , David Bruge , Hans-Peter Buchstaller , Ulrich Emde , Kai Schiemann , Wolfgang Staehle , Christiane Amendt , Nina Heiss , Frank Zenke
发明人: Dirk FINSINGER , David Bruge , Hans-Peter Buchstaller , Ulrich Emde , Kai Schiemann , Wolfgang Staehle , Christiane Amendt , Nina Heiss , Frank Zenke
IPC分类号: A61N5/00 , A61K31/451 , A61K31/435 , A61K31/5375 , A61P35/02 , A61K31/122 , A61K31/4525 , A61K31/4545 , A61K31/496 , A61P35/00 , A61K31/137 , A61K31/495
CPC分类号: C07D405/08 , C07C45/46 , C07C49/67 , C07C49/747 , C07C49/755 , C07C225/22 , C07C255/56 , C07D211/14 , C07D211/70 , C07D221/16 , C07D295/03
摘要: Compounds of the formula (I), in which R1, R2, R3, R4, and q have the meanings indicated in Claim 1, can be employed, inter alia, for the treatment of tumours.
摘要翻译: 其中R1,R2,R3,R4和q具有权利要求1所示含义的式(I)化合物可特别用于治疗肿瘤。
-
公开(公告)号:US20090118267A1
公开(公告)日:2009-05-07
申请号:US11817757
申请日:2006-02-13
申请人: Dirk Finsinger , David Bruge , Hans-Peter Buchstaller , Ulrich Emde , Kai Schiemann , Wolfgang Staehle , Christiane Amendt , Nina Heiss , Frank Zenke
发明人: Dirk Finsinger , David Bruge , Hans-Peter Buchstaller , Ulrich Emde , Kai Schiemann , Wolfgang Staehle , Christiane Amendt , Nina Heiss , Frank Zenke
IPC分类号: A61K31/5375 , C07C211/28 , C07D211/70 , C07D221/16 , C07D265/30 , C07D241/04 , A61K31/4525 , A61K31/496 , A61K31/4545 , A61K31/4965 , C07D405/02 , C07D401/06 , A61K31/135 , A61K31/445
CPC分类号: C07D405/08 , C07C45/46 , C07C49/67 , C07C49/747 , C07C49/755 , C07C225/22 , C07C255/56 , C07D211/14 , C07D211/70 , C07D221/16 , C07D295/03
摘要: Compounds of the formula (I), in which R1, R2, R3, R4, and q have the meanings indicated in claim 1, can be employed, inter alia, for the treatment of tumours.
摘要翻译: 其中R1,R2,R3,R4和q具有权利要求1所述含义的式(I)化合物可用于治疗肿瘤。
-
公开(公告)号:US07915416B2
公开(公告)日:2011-03-29
申请号:US11631185
申请日:2005-06-03
申请人: Kai Schiemann , David Bruge , Hans-Peter Buchstaller , Dirk Finsinger , Wolfgang Staehle , Christiane Amendt , Ulrich Emde , Frank Zenke
发明人: Kai Schiemann , David Bruge , Hans-Peter Buchstaller , Dirk Finsinger , Wolfgang Staehle , Christiane Amendt , Ulrich Emde , Frank Zenke
IPC分类号: C07D215/38
CPC分类号: C07D491/04
摘要: Disclosed are compounds of formula (I), wherein W, R, R1, R2, R3, R4, R5, R6, and R7 have the meanings indicated in claim 1. Said compounds can be used for the treatment of tumors, among other things.
摘要翻译: 公开了式(I)的化合物,其中W,R,R 1,R 2,R 3,R 4,R 5,R 6和R 7具有权利要求1中所示的含义。所述化合物可用于治疗肿瘤, 。
-
公开(公告)号:US20090030028A1
公开(公告)日:2009-01-29
申请号:US11631185
申请日:2005-06-03
申请人: Kai Schiemann , David Bruge , Hans-Peter Buchstaller , Dirk Finsinger , Wolfgang Staehle , Christiane Amendt , Ulrich Emde , Frank Zenke
发明人: Kai Schiemann , David Bruge , Hans-Peter Buchstaller , Dirk Finsinger , Wolfgang Staehle , Christiane Amendt , Ulrich Emde , Frank Zenke
IPC分类号: A61K31/436 , A61P35/00 , C07D491/056
CPC分类号: C07D491/04
摘要: Disclosed are compounds of formula (I), wherein W, R, R1, R2, R3, R4, R5, R6, and R7 have the meanings indicated in claim 1. Said compounds can be used for the treatment of tumors, among other things.
摘要翻译: 公开了式(I)的化合物,其中W,R,R 1,R 2,R 3,R 4,R 5,R 6和R 7具有权利要求1中所示的含义。所述化合物可用于治疗肿瘤, 。
-
5.Tetrahydroquinolines for Use as Modulators of the Mitotic Motor Protein Eg5 有权
标题翻译: 用作有丝分裂运动蛋白的调节剂的四氢喹啉Eg5公开(公告)号:US20080200451A1
公开(公告)日:2008-08-21
申请号:US11917309
申请日:2006-06-02
申请人: Kai Schiemann , David Bruge , Hans-Peter Buchstaller , Ulrich Emde , Dirk Finsinger , Christiane Amendt , Frank Zenke
发明人: Kai Schiemann , David Bruge , Hans-Peter Buchstaller , Ulrich Emde , Dirk Finsinger , Christiane Amendt , Frank Zenke
IPC分类号: A61K31/47 , C07D215/14 , C07D215/54 , C07D487/08 , A61K31/55 , A61P35/00
CPC分类号: C07D471/08 , C07D215/12 , C07D215/42 , C07D215/54 , C07D221/06 , C07D405/04 , C07D409/04
摘要: Compounds of the formula (I), in which W, R, R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in claim 1, can be employed, inter alia, for the treatment of tumours.
摘要翻译: 其中W,R,R 1,R 2,R 3,R 4,R 4,R 4, R 5,R 6,R 7和R 7具有权利要求1中所示的含义,特别可以用于 治疗肿瘤。
-
公开(公告)号:US08110583B2
公开(公告)日:2012-02-07
申请号:US11917283
申请日:2006-05-31
申请人: Wolfgang Staehle , David Bruge , Kai Schiemann , Dirk Finsinger , Hans-Peter Buchstaller , Frank Zenke , Christiane Amendt
发明人: Wolfgang Staehle , David Bruge , Kai Schiemann , Dirk Finsinger , Hans-Peter Buchstaller , Frank Zenke , Christiane Amendt
IPC分类号: A61K31/473 , C07D221/06
CPC分类号: C07D491/04 , C07D221/16
摘要: Compounds of the formula I, in which s, k, I, W, R1, R2, R3, and U have the meanings indicated in claim 1, can be employed, inter alia, for the treatment of tumours.
摘要翻译: 其中s,k,I,W,R 1,R 2,R 3和U具有权利要求1所示含义的式I化合物可用于治疗肿瘤。
-
7.Tetrahydroquinolines for use as modulators of the mitotic motor protein Eg5 有权
标题翻译: 用作有丝分裂运动蛋白Eg5的调节剂的四氢喹啉公开(公告)号:US08207345B2
公开(公告)日:2012-06-26
申请号:US11917309
申请日:2006-06-02
申请人: Kai Schiemann , David Bruge , Hans-Peter Buchstaller , Ulrich Emde , Dirk Finsinger , Christiane Amendt , Frank Zenke
发明人: Kai Schiemann , David Bruge , Hans-Peter Buchstaller , Ulrich Emde , Dirk Finsinger , Christiane Amendt , Frank Zenke
IPC分类号: C07D405/00 , C07D215/00
CPC分类号: C07D471/08 , C07D215/12 , C07D215/42 , C07D215/54 , C07D221/06 , C07D405/04 , C07D409/04
摘要: Compounds of the formula (I), in which W, R, R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in Claim 1, can be employed, inter alia, for the treatment of tumors.
摘要翻译: 其中W,R,R 1,R 2,R 3,R 4,R 5,R 6和R 7具有权利要求1所述的含义的式(I)化合物,尤其可用于治疗肿瘤。
-
公开(公告)号:US20080221118A1
公开(公告)日:2008-09-11
申请号:US11917283
申请日:2006-05-31
申请人: Wolfgang Staehle , David Bruge , Kai Schiemann , Dirk Finsinger , Hans-Peter Buchstaller , Frank Zenke , Christiane Amendt
发明人: Wolfgang Staehle , David Bruge , Kai Schiemann , Dirk Finsinger , Hans-Peter Buchstaller , Frank Zenke , Christiane Amendt
IPC分类号: A61K31/496 , C07D221/06 , C07D471/04 , C07D401/10 , A61K31/473 , A61K31/4741 , A61P35/00 , A61P35/02
CPC分类号: C07D491/04 , C07D221/16
摘要: Compounds of the formula I, in which s, k, I, W, R1, R2, R3, and U have the meanings indicated in claim 1, can be employed, inter alia, for the treatment of tumours.
摘要翻译: 其中s,k,I,W,R 1,R 2,R 3和U的式I化合物具有 权利要求1所述的含义可以用于治疗肿瘤。
-
公开(公告)号:US20070213374A1
公开(公告)日:2007-09-13
申请号:US10563830
申请日:2004-06-18
申请人: David Bruge , Hans-Peter Buchstaller , Matthias Wiesner , Dirk Finsinger , Manfred Baumgarth , Christian Sirrenberg , Frank Zenke , Christian Amendt , Matthias Grell
发明人: David Bruge , Hans-Peter Buchstaller , Matthias Wiesner , Dirk Finsinger , Manfred Baumgarth , Christian Sirrenberg , Frank Zenke , Christian Amendt , Matthias Grell
IPC分类号: A61K31/395 , A61K31/422 , C07C233/15 , C07D213/38 , C07D213/66 , C07D213/68 , C07D213/75 , C07D213/79 , C07D213/81 , C07D261/14 , C07D413/12
CPC分类号: C07D213/66 , C07C233/15 , C07D213/38 , C07D213/68 , C07D213/75 , C07D213/79 , C07D213/81 , C07D261/14 , C07D413/12
摘要: The present invention relates to malonamide derivatives of formula A-D-B-1, as inhibitors of raf-kinase and the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition.
摘要翻译: 本发明涉及作为raf-激酶抑制剂的式A-D-B-1的丙二酰胺衍生物和式(I)化合物在制备药物组合物中的用途。
-
公开(公告)号:US08420820B2
公开(公告)日:2013-04-16
申请号:US13002168
申请日:2009-06-04
申请人: Margarita Wucherer-Plietker , David Bruge , Dirk Finsinger , Ulrich Graedler , Dieter Dorsch , Christina Esdar
发明人: Margarita Wucherer-Plietker , David Bruge , Dirk Finsinger , Ulrich Graedler , Dieter Dorsch , Christina Esdar
IPC分类号: C07D471/02 , C07D413/00
CPC分类号: C07D471/04
摘要: Compounds of the formula I in which X, R1, R2, R3, R4 and R6 have the meanings indicated in Claim 1, are inhibitors of cell proliferation/cell vitality and can be employed for the treatment of tumours.
摘要翻译: 其中X,R 1,R 2,R 3,R 4和R 6具有权利要求1所述含义的式I化合物是细胞增殖/细胞活力的抑制剂,可用于治疗肿瘤。
-
-
-
-
-
-
-
-
-